Tuesday, 31 March 2026

March 2026 Updates

March is a comparatively busy month for me both at work and in the market.
 
Dividends received
 
MLT @ $296.01
MIT @ $285.30
Ascendas REIT @ $1,038.86
CICT @ $331.92
CLCT @ $349.50 (last dividend)
 
Total received for March 2026: $2,301.59

This amount is slightly higher year on year.
 
Transactions
 
1) This month marks the end of my relationship with CapitaLand China Trust aka CLCT after holding it for 6 years.
 
I've sold all my 15,000 units at $0.675. Overall loss incurred is -47.24% including cumulative dividends over the years.
 
This is following my review of portfolio done in January this year.
 
What prompted me to sell is the structural deterioration in the REIT's performance, continuous challenging macro environment and most importantly, I don't see an improvement in sight in the near future.
 
Performance of the REIT manager is nothing short of shocking. Rental reversion is in the negative territory across the three segments of retail, logistics park and business park.
 
Retail, which is traditionally their largest portfolio contributor, seen a fall in both revenue and occupancy rate.

Consequently DPU fell nearly 15% compared to 2024.

As such I have to make the decision to cut this bleeding counter from my portfolio and reinvest the proceeds into other more resilient and promising counters.

It is a painful but necessary decision.

2) Using the proceeds from above sale and dividends received, I added more CapitaLand Integrated Commercial Trust (CICT) at $2.37 and $2.30.
 
This brought my average price to $1.93. An average up.
 
Dividend yield on average cost: 6%.
 
CICT is one of the few REITs that performed admirably in my opinion. Their latest financial results show a solid performance with both revenue and NPI increasing year on year. Occupancy rate remains high at nearly 97%.
 
I also like the fact that gearing remains below 40% with ICR increasing YoY. Equally important, cost of debt went down to 3.2% and is set to go down even further to about 3.0% in FY2026. Nice!

No qualms in increasing my holdings in this counter which currently makes up about 9.2% of my portfolio.

3) Also using the proceeds and dividends, I bought into Centurion Accomodation REIT (Cent Accom REIT) at $1.09.

This is a counter that I have been wanting to buy after failing to get any allocation during IPO.

Based on a prudent IPO projected dividend amount (they have apparently exceeded this forecasted amount), my yield on cost would be 6.03%.

Even after taking 10% off - the REIT has stated after 2027 they would pay out at least 90% of distributable income instead of the 100% now, my yield would be 5.43%. Still quite decent.
 
So long as Singapore remains a foreign worker-based economy, I'm optimistic about this counter. Looking to build up this holding in tranches.

4) I also applied for the UI Boustead REIT IPO this month and got allocated 3,200 units. The listing couldn't come at a worse time with the war in Middle East raging on.

Share price of this counter went downhill on day one of listing and has remained below the IPO price although I feel this is a reaction to the macro environment rather than structural issues with the counter.

Can add more depending on my funds and opportunities with other counters.

5) ABVX put option that I wrote last month has expired. Premium in the pocket remains intact.

6) Bought ABVX at $119.77 and $102.76 post-earnings. First came across this counter when it was mentioned by Doc TTI. Wasn't in a hurry to enter then as I wanted to wait for the earning release.

It's not about the numbers - For biotech companies at this stage, the financial numbers are pretty meaningless. What I wanted to read is the management comments and business updates. And these didn't disappoint.

Two points I picked up in the updates:

- Firstly, a Chief Commercial Officer is appointed and the Chief Scientific Officer is leaving. I interpret this as: the company do not foresee any issue with Obefazimod and the planned NDA application in the 2nd half of the year. Even if no buyout materialised, the company is prepared to market the drug themselves.

- Secondly the Data Safety Monitoring Board found no new safety signals in the latest ABTECT Phase 3 maintenance trial.

First point spells confidence. Second point further reinforce the first.

The potential of Obefazimod doesn't just ends here. Because of the delivery mechanism, the drug has high potential of application in most other inflammatory diseases as well. The company is concurrently running trials on Obefazimod for Crohn's disease now with the 12-week induction data expected in second half 2026.
 
The more due diligence I do for this counter, the more excited I am. This drug is like a game-changer in that it reduces inflammation in the first place by deregulating the release of cytokines which are pro-inflammatory proteins in our body.

This is radically different from the immunosuppressants that are usually prescribed in current practice which can cause a host of other issue because of weakened immune system.

So in my opinion even if no buyout occurs, the commercialisation of the drug by Abivax themselves isn't a bad thing too.

Risk of this investment is obviously the failure to get NDA approval for Obefazimod. However this is probably a low risk and I am mitigating with position sizing.
 
The question now is how much of the good news has been priced in already. My feel is not fully yet. So I will continue to add and build up for this counter.

7) Took partial profits off my MSFT holdings at $370.28 partly because of the recent price weakness and partly to fund my planned purchases of ABVX.
 
MSFT has been a multi-bagger for me and I still hold the counter after this partial profit-taking.

Conclusion

Same strategy applies for all counters. Since the current war situation is so dynamic - market can move in any direction in the blink of an eye based on one social media post from Donald Trump, I will continue to buy in tranches and at the same time mitigate risk with position sizing.

Monday, 30 March 2026

Goodbye Xiao Lan, Hello Da Bai

 
After serving me and my loved ones faithfully for the past 7 years, I finally had to part with my workhorse Xiao Lan.
 
It was honestly not an easy decision. Even a pen if used for long, I will find it hard to throw it away.

However judging from the government's policy on cars, I think it's pretty clear EV is the future and if I don't cash in on the remaining value now, it would be pretty taxing for me in 3 years time when I have to change car. Who knows how much the COE will cost by then.

As a matter of fact, COE for my first car in 2009 was $4,000+.
 
COE for my second car which is Xiao Lan was $26,301.00.

COE for my new car which I got in February this year is $108,220.00.

I still remember I got Xiao Lan when my daughter was around 9 months old and since then she has ferried us around. She was also the one who fetched my son home after he was discharged from hospital after birth.

On a personal note, Xiao Lan has accompanied me through my many ups and downs and has never given me any major problem for the years I've been with her. She's robust.
 
She is such an easy drive. When I'm with her I understand the feeling of 车人合一.

I am still missing her after parting with her on 13/3/2026. So do our whole family. We took a family photo with her on the day of parting.
 
It is my good fortune to have you, Xiao Lan. Good bye and all the best. I hope to see you on the road one day.
 

Da Bai came into our family on the day Xiao Lan left. I have since driven her for slightly more than 2 weeks with slightly more than 1,000 km mileage.
 
It seems almost fated to have Da Bai. I visited the showroom because the agent for another brand was having his day off when I called. I then decided to visit Da Bai's showroom with the intention to just get a best deal for comparison.

However the agent who served me was so sincere and I managed to get almost whatever I asked for. In the end I put pen to paper and confirmed my relationship with Da Bai on the spot.
 
I am slowly getting used to Da Bai now. She has lot more functions than Xiao Lan, not least the voice command which the kids loved to play with.
 
"Hello Baby. Please open the sunshade."
 
"Hello Baby. Please turn on the aircon."
 
"Hello Baby. Please play some music."
 
I guess Da Bai is also a head turner. Recently a lady approached me to chat about the car. She said she has seen my car for 2 days already and was hoping to catch the owner.
 
Also unlike what others said, there is no range anxiety for me at all. I don't actually understand why would some people feel that.
 
EV chargers are everywhere now. Nowadays when I enter a carpark I just move into the EV charging lot, plug in and go run my errands. When I get back I just remove the plug and drive off. Just like juicing up your phone whenever you see a wall socket.

It doesn't matter how much it got juiced up. Just let the charging do the job in the time the car is idling in the parking lot while you do your stuff.
 
To me this is the premise of EV. To charge while you do your stuff. Not finding stuff to do while charging.
 
Couple of days ago I had this shiok experience. I was meeting a friend at Ang Mo Kio for lunch and the carpark was full with several cars waiting for parking lot.
 
I literally just drove into an EV charging lot, plug in and went off to meet my friend.
 
I will probably write a review on Da Bai, maybe with the running cost too, when I get to know her deeper.
 
For now I'll continue to tinkle and have fun with the different functions.

Tuesday, 3 March 2026

My Review of Yuen Kee Dumpling

TL:DR: I wouldn't queue more than 15 min for Yuen Kee. At least not for myself. 

Have walked past the Yuen Kee Dumpling outlet at Fortune Centre many times on weekends and there is always a long queue outside without fail.

Nevertheless I never had the urge to try it until recently when wifey told me of her favourable experience at another outlet.

So today I made a trip down to Fortune Centre and lucky me, there is a seat for me almost immediately. I guess being a weekday and being alone helps!

The outlet is pretty small with probably 20 seats or so. Didn't really count.

Ordering is pretty standard. Via the self ordering kiosk outside or by scanning the QR code on the table. 


So here's my take:

I ordered the corn and pork dumpling with scallion oil noodles along with a side of fried pork wanton. No drink was ordered. 

The dumplings are pretty interesting in flavour. The corns add a refreshing crunch and help to balance out the taste of the pork.

The noodles are a disappointment in both texture and flavour. The al dente element that I was looking out for is missing. The all-important scallion oil flavour is lacking.

The fried pork wanton comes with thin skin which is evidently different from other places. The wanton I had were fried to a crisp but I find them a tad too oily. After four pieces I had to stop eating the skin. The wanton flavour doesn't lingers in my mind too.

Service-wise can't be faulted. The staff is friendly and efficient. The chilli oil is empty though and I had to make do with whatever I can scoop out. Not really a big deal to me anyway. 

Verdict: I wouldn't queue more than 15 min for Yuen Kee. At least not for myself. 

Luckily I got a seat almost right away just now.

Overall food: 3/5
Service: 3.5/5
Ambience: 3/5

Sunday, 1 March 2026

February 2026 Updates - Tale of 3 Purchases and 2 Sales

1st purchase
 
I've finally decided not to be held hostage by the oil companies anymore. These people hike up their pump price whenever there is justification but take ages to reduce when crude price comes down.
 
I took the plunge and bought an EV last Friday.
 
Have been thinking about this for some time because of the above but what firmed up my mind to make the move are three primary reasons:
 
Firstly, my current car is left with less than four years of COE. While there is still time to consider my choices, the trade-in value also correspondingly goes down with time.
 
Secondly, I saw a report recently which states that the number of COE to be released in the coming quarter will be reduced. This is in contrary to what I have thought.

Last but not least, the move by the government to reduce the PARF rebate recently shows that they are firm on their push towards EVs for the local roads.
 
I have actually narrowed my choice to two models recently - BYD Seal 6 and Aion V.
 
The plan is to compare both and take the one that offers the best deal.
 
So last Friday I have planned to go to the BYD showroom. However the sales contact that I had was on his off day. So I popped by the Aion showroom instead.
 
Long story short, what was supposed to be a chat to get the best package evolved into a purchase because the sales person managed to give me what I want.
 
I was impressed by the test drive too. So was wifey who sat as a rear passenger.
 
Honestly, it's hard to find another SUV in the market at this price point that comes close to the spaciousness, features and comfort that the Aion V offers.
 
2nd purchase
 
Second purchase also happened on the same day - Ascendas REIT.
 
This is an accumulation to existing holdings.
 
Have been queuing at $2.69 for couple of days and managed to get it on the last trading day on the month. Was pretty sure I would get it sooner or later since this price has been tested a few times over the week already.
 
As mentioned before for this counter, anything less than $2.70 is a buy.
 
3rd purchase and 1st sale
 
Tried the OCBC precious metals account. Bought my first tranche of paper silver and sold them slightly more than two weeks later for a profit of S$466.14.
 
2nd sale
 
This is for a put option that I wrote for a premium of US$2.80.

Big news

The strike by Israel and the US on Iran, and the subsequent retaliatory strikes by the latter on Israel and US bases around Middle East have a definite impact on various markets. However the magnitude and how long it stays on the temporal scale remains to be seen.

To me it all boils down to one person - Donald Trump, and how wide he wants this latest conflict to be.

Ultimately when this guy wage a war, it all boils down to one thing - oil. Same for Venezuela, same for Iran.

It's so delusionary that he feels he should be getting the Nobel Peace Prize.

So what's this means for me on the investment front?

On my main income portfolio, it probably means suddenly there would be more opportunities at least in the coming week to add new counters that I have been eyeing or accumulate to existing positions.

On the put option that I've just sold, I have to wait and see if the counter dives. Fundamentally the counter is pretty solid. However if I gets assigned I would take it up since the strike price is one which I am comfortable to pay for owning this counter.

On the precious metals side, it seems like they have already ran up and logically so since it's a flight to safety for investors. For me I would wait for the next opportunity to trade for this asset class.

On the more immediate front, I need to go top up petrol now before anything else.

Ciao!